Home > News > Headline News > Archive

Click on title to read the full article.

A Mainstay of Breast Cancer Treatment, Cytotoxics Class Must Grow

November 29, 2012

By Julian Kaye, OncLive

Despite the trend toward targeted therapies, cytotoxic drugs remain a mainstay of metastatic breast cancer (MBC) treatment, and new therapies in that class are needed, according to Joyce A. O’Shaughnessy, MD.

Mammograms Are Not Effective In Lowering Breast Cancer Death Rates

November 25, 2012

By MedNews Today

During the last 30 years, millions of women have been diagnosed with breast cancer. Although screenings with mammograms are often used, the prevalence of metastatic breast cancer has not changed and there has been no reduction in the rate of cancer being diagnosed in late stages, according to a recent study published in the New England Journal of Medicine conducted by researchers at The Dartmouth Institute for Healthy Policy & Clinical Practice in Lebanon, N.H.